Successful left ventricular assist device bridge to transplantation in a patient with end-stage heart failure and human immunodeficiency virus

Artificial Organs

Volumn 36, Issue 8, 2012, Pages 759-

  Krishan, Kewal ^a   Pinney, Sean ^b   Anyanwu, Anelechi C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBER OPTIC SENSORS; LEFT VENTRICULAR ASSIST DEVICES;

HEART FAILURE; HUMAN IMMUNODEFICIENCY VIRUS;

VIRUSES;

ADULT; CASE REPORT; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LEFT VENTRICULAR ASSIST DEVICE; LETTER; MYOCARDIAL BRIDGING; NONISCHEMIC CARDIOMYOPATHY; ORGAN DONOR; PRIORITY JOURNAL; TREATMENT CONTRAINDICATION; TRICUSPID VALVE REPAIR;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84864828789     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2012.01498.x     Document Type: Letter

References (4)

1. Mancini MM, Kunavarapu C, Edwards NM, Chen JM, Mazzeo PA, eds. Recipient Selection in Cardiac Transplantation. Totowa, NJ: Humana Press, 2004;1-18.
2. Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, Porter K, Walker SA. CASCADE collaboration determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 2003;362:1267-74.
3. Palella FJ Jr, Delaney KM, Moorman AC, etal. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
4. Bisleri G, Morgan JA, Deng MC, Mancini DM, Oz MC. Should HIV-positive recipients undergo heart transplantation? J Thorac Cardiovasc Surg 2003;126:1639-40.